Costa Mesa, CA, United States of America

Julia Herrmann

This inventor holds 1 USPTO granted patent. Top assignee: Allergan, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia Herrmann. Retrieved from https://idiyas.com/inventor/julia-herrmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia Herrmann: Innovator in Prostanoid Receptor Agonist Compounds

Introduction

Julia Herrmann is a notable inventor based in Costa Mesa, CA (US). She has made significant contributions to the field of pharmacology, particularly in the development of prostanoid receptor agonist compounds. Her work is essential for advancing treatments for various medical conditions.

Latest Patents

Julia holds a patent for "Prostanoid receptor agonist compounds and methods of use for same." This patent includes embodiments directed to prostanoid (IP) receptor agonist compounds, such as cicaprost and certain prodrugs. The methods described in her patent focus on the preparation and use of these compounds in treating topical and ocular conditions.

Career Highlights

Julia is currently employed at Allergan, Inc., a leading company in the pharmaceutical industry. Her role involves research and development of innovative treatments that can improve patient outcomes. With her expertise, she has contributed to the advancement of medical science.

Collaborations

Julia has collaborated with notable colleagues, including Jenny W Wang and David Frederick Woodward. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Julia Herrmann's work in prostanoid receptor agonist compounds exemplifies her commitment to improving healthcare through innovation. Her contributions are vital for the development of effective treatments for various conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…